These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3956136)

  • 41. Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus.
    Ruane PJ; Morgan MA; Citron DM; Mulligan ME
    J Clin Microbiol; 1986 Sep; 24(3):490-2. PubMed ID: 3489732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of ceftazidime in combination with other antibiotics.
    Simon C; Littschwager G
    Infection; 1985; 13(4):184-9. PubMed ID: 3930407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
    Shelburne SA; Musher DM; Hulten K; Ceasar H; Lu MY; Bhaila I; Hamill RJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4016-9. PubMed ID: 15388469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection].
    Ji M; Lee M; Noh S; Kim MN
    Korean J Lab Med; 2010 Dec; 30(6):637-46. PubMed ID: 21157151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R; Raad I
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
    Credito K; Lin G; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1504-7. PubMed ID: 17220402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils.
    Yancey RJ; Sanchez MS; Ford CW
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):107-13. PubMed ID: 1864272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro synergistic effects of various combinations of vancomycin and non-beta-lactams against Staphylococcus aureus with reduced susceptibility to vancomycin.
    Kang YR; Chung DR; Kim J; Baek JY; Kim SH; Ha YE; Kang CI; Peck KR; Song JH
    Diagn Microbiol Infect Dis; 2016 Nov; 86(3):293-299. PubMed ID: 27591174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic Potential of Antimicrobial Combinations Against Methicillin-Resistant
    Yu Y; Huang HL; Ye XQ; Cai DT; Fang JT; Sun J; Liao XP; Liu YH
    Front Microbiol; 2020; 11():1919. PubMed ID: 33013731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
    Barr JG; Smyth ET; Hogg GM
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom.
    van der Plas MJ; Dambrot C; Dogterom-Ballering HC; Kruithof S; van Dissel JT; Nibbering PH
    J Antimicrob Chemother; 2010 May; 65(5):917-23. PubMed ID: 20189943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High oxacillin, vancomycin and fluoroquinolone resistance amongst biofilm forming Staphylococcus aureus isolates from ulcerative keratitis infections.
    Singh S; Katiyar R; Kaistha SD
    Indian J Med Microbiol; 2011; 29(3):312-3. PubMed ID: 21860118
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Lozniewski A; Lion C; Mory F; Weber M
    J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.